Prospective molecular biological and serological examination for the detection of SARS-CoV-2 (COVID-19) in employees of a hospital of regular care in Germany

Organizational Data

DRKS-ID:
DRKS00021270
Recruitment Status:
Recruiting ongoing
Date of registration in DRKS:
2020-04-15
Last update in DRKS:
2020-12-01
Registration type:
Retrospective

Acronym/abbreviation of the study

ProCoV

URL of the study

No Entry

Brief summary in lay language

There is no reliable data on the real spread of SARS-CoV-2 in the population. Representative studies would therefore be necessary. A representative population group could be all hospital employees, from cleaning staff to administrative staff to nurses and doctors. At least this would be a representative group of employees in the health service. All employees are included in this prospective observational study to detect SARS-CoV-2 by repeated molecular test and repetitive antibody test. This data will be correlated to a daily performed online survey. All data will be evaluated all 3 months to detect spreading pattern.

Brief summary in scientific language

There is no reliable data on the actual prevalence of SARS-CoV-2 in the population. Representative studies would therefore be necessary. A representative population group could be all hospital employees, from cleaning staff to administrative staff to nurses and doctors. At least this would be a representative group of healthcare workers. All employees are included in this prospective observational study to demonstrate SARS-CoV-2 through repeated molecular tests and repeated antibody tests. For this purpose, a weekly smear for PCR on SARS-CoV-2 and weekly antibody tests are carried out. In addition, blood samples are preserved for testing for seroconversion. This data is correlated with a daily online survey. All data are evaluated every 3 months to determine the spread pattern.

Health condition or problem studied

ICD10:
U07.1 - COVID-19, virus identified
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
All employees at Reinbek Hospital are smeared weekly on COVID-19 and a blood sample is taken for the antibody test. At the same time, a daily online survey of the state of health takes place.

Endpoints

Primary outcome:
How many employees develop a COVID-19 positive test and how many develop antibodies in the sense of a seroconversion?
Secondary outcome:
Correlation between symptoms and positive test results Do certain groups show certain symptoms and certain courses?

Study Design

Purpose:
Screening
Retrospective/prospective:
No Entry
Study type:
Non-interventional
Longitudinal/cross-sectional:
No Entry
Study type non-interventional:
No Entry

Recruitment

Recruitment Status:
Recruiting ongoing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • Medical center Krankenhaus Reinbek St. Adolf-Stift Reinbek

Recruitment period and number of participants

Planned study start date:
2020-04-14
Actual study start date:
2020-04-14
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
900
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
All
Minimum Age:
16 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
Actually working in the study center

Exclusion Criteria

No informed consent

Addresses

Primary Sponsor

Address:
Krankenhaus Reinbek St. Adolf-Stift
Björn Pestinger
Hamburger Straße 41
21465 Reinbek
Germany
Telephone:
00494072803300
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://krankenhaus-reinbek.de
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Krankenhaus Reinbek St. Adolf-Stift
Prof. Dr. med. Tim Strate
Hamburger Straße 41
21465 Reinbek
Germany
Telephone:
00494072803300
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.krankenhaus-reinbek.de

Contact for Public Queries

Address:
Krankenhaus Reinbek St. Adolf-Stift
Dr. med. Jonas Herzberg
Hamburger Straße 41
21465 Reinbek
Germany
Telephone:
00494072803300
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.krankenhaus-reinbek.de

Principal Investigator

Address:
Krankenhaus Reinbek St. Adolf-Stift
Prof. Dr. med. Tim Strate
Hamburger Straße 41
21465 Reinbek
Germany
Telephone:
00494072803300
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.krankenhaus-reinbek.de

Sources of Monetary or Material Support

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Krankenhaus Reinbek St. Adolf-Stift
Hamburger Straße 41
21465 Reinbek
Germany
Telephone:
00494072800
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://krankenhaus-reinbek.de

Ethics Committee

Address Ethics Committee

Address:
Ärztekammer Schleswig-Holstein, Ethik-Kommission
Bismarckallee 8-12
23795 Bad Segeberg
Germany
Telephone:
+49-4551-803152
Fax:
+49-4551-803214
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2020-04-08
Ethics committee number:
038/20 I
Vote of the Ethics Committee:
Approved
Date of the vote:
2020-04-14

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No
IPD Sharing Plan:
Because of the use of high sensible health data, according to the ICMJE there will be no sharing of individual participant data at all. No other data in particular will be shared. The study protocol will be available. All other data will not be available.

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
Publikation im International Journal of Infectious Diseases
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry